Market Overview - The Shanghai Composite Index closed at 3519.65 points, above the annual line, with a change of 0.27% [1] - The total trading volume of A-shares reached 14809.22 billion yuan [1] Stocks Breaking Annual Line - A total of 46 A-shares have surpassed the annual line today, with notable stocks including: - Siyuan Electric (002028) with a deviation rate of 7.62% - Huaming Equipment (002270) with a deviation rate of 2.75% - Tongyi Co., Ltd. (300538) with a deviation rate of 2.63% [1] Deviation Rate Rankings - The top stocks with the highest deviation rates from the annual line include: - Siyuan Electric: 10.00% increase, latest price 76.99 yuan, deviation rate 7.62% - Huaming Equipment: 3.25% increase, latest price 16.85 yuan, deviation rate 2.75% - Tongyi Co., Ltd.: 2.63% increase, latest price 16.02 yuan, deviation rate 2.63% [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Daqin Railway and *ST Haiyuan with minimal deviation rates [1]

证券代码：301267 证券简称：华厦眼科 公告编号：2025-021 华厦眼科医院集团股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指 引第 9 号——回购股份》等相关规定，华厦眼科医院集团股份有限公司（以下简 称"公司"或"本公司"）回购专用账户中的股份不参与本次权益分派。公司 2024 年年度权益分派以当前总股本 840,000,000 股剔除已回购股份 7,527,840 股 后的 832,472,160 股为基数，向全体股东每 10 股派发现金红利人民币 2.20 元（含 税），合计派发现金红利 183,143,875.20 元。 2、本次权益分派实施后计算除权除息价格时，以公司总股本（含回购股份， 即 840,000,000 股）折算后的每 10 股现金红利（含税）=现金分红总额/总股本（含 回购股份）*10=183,143,875.20 元/840,000,000 股*10=2.180284 元（保留六位小 数，最后一位直 ...

Core Viewpoint - Huaxia Eye Hospital Group, in collaboration with Shanghai University, Nova Coffee, and Shanghai Xin'ao Guangming Public Welfare Foundation, launched the "Eye Health Dry Eye Moisturizing Public Welfare Activity and Technology Innovation Platform Release Ceremony," introducing the first AI self-test tool for dry eye in China, named "Smart Eye Guardian" [1][2]. Group 1: AI Self-Test Tool - The "Smart Eye Guardian" mini-program is the first AI self-test tool for dry eye in China, allowing users to upload images and videos for quick, contactless preliminary diagnosis of dry eye symptoms [2][3]. - The program aims to address the increasing prevalence of dry eye, which affects approximately 360 million people in China, growing at a rate of 10% annually [3]. Group 2: Public Health Challenge - The World Health Organization reports that over 2 billion people globally spend more than 8 hours a day on screens, with about 35% experiencing dry eye symptoms [3]. - The rise of digital device usage has led to a significant increase in dry eye cases, highlighting the need for innovative solutions like the "Smart Eye Guardian" [3]. Group 3: Collaborative Initiatives - Huaxia Eye Hospital partnered with Nova Coffee to launch the "Good for Eyes" blueberry beverage, targeting the 20-45 age group, which faces higher risks of dry eye due to busy lifestyles and lack of awareness [4]. - The collaboration includes a public welfare project where 0.1 yuan from each "nourishing coffee" sold will be donated to a public welfare fund, promoting a "consumption equals public welfare" model [4]. Group 4: Community Engagement - Over 50 hospitals under Huaxia Eye Hospital will participate in eye health public welfare projects, conducting a series of dry eye care activities in the coming month [4]. - The initiative aims to fill the gap in dry eye health education and patient care, focusing on preventive measures and raising awareness among high screen-time populations [4]. Group 5: Professional Insights - Experts emphasized the importance of understanding the causes and development of dry eye, advocating for good lifestyle habits to prevent the condition [5]. - The misconception that dry eye is untreatable was addressed, with experts stating that all cases can be effectively treated once the underlying causes are identified [5].

Core Viewpoint - The collaboration between Huaxia Eye Hospital Group, Shanghai University, Nova Coffee, and Shanghai Xin'ao Guangming Public Welfare Foundation aims to redefine the boundaries of ophthalmic healthcare through innovation and integration of industry, academia, and research [1][3]. Group 1: Industry Collaboration - The establishment of the "Ophthalmic Technology Joint Transformation Center" signifies a commitment to the transformation and application of ophthalmic technologies, leveraging Shanghai University's research strengths and Huaxia Eye Hospital's clinical experience [3]. - The center aims to promote deep integration of industry, academia, and research, aligning with China's health strategy to enhance technological innovation and industrial upgrading [3]. Group 2: AI and Healthcare Innovation - The launch of the "Smart Eye Guardian" AI self-test tool marks a significant advancement in dry eye screening, filling a gap in domestic intelligent screening and extending traditional hospital screening to end-users [5]. - With over 2 billion people globally using screens for more than 8 hours daily, and 35% experiencing dry eye symptoms, the tool addresses a pressing healthcare need [5]. Group 3: Public Welfare Initiatives - Huaxia Eye Hospital has initiated a public welfare project by donating 10,000 dry eye experience services to Shanghai University students and alumni, integrating professional medical services with high eye-use consumer scenarios [7]. - The collaboration with Nova Coffee aims to make public welfare services more accessible and participatory, blending corporate activities with social responsibility [7][8]. - The initiative reflects a forward-looking approach to the "big health" ecosystem, exploring innovative models that combine healthcare and consumer engagement [8].

随着数字化浪潮席卷全球，大众眼健康正面临严峻挑战。世界卫生组织数据显示，全球超20亿人日均屏幕使用时长超8小时，其中约35%出现干眼症。据《国人干眼多中心大数据报告》显示，中 正值全国爱眼月期间，华厦眼科医院集团联合上海大学、挪瓦咖啡、上海新奥光明公益基金会联合举办"眼健康干眼润目公益活动暨科技创新平台发布仪式"，发布全国首个干眼AI自测工具，启 科技赋能：国内首个干眼AI自测工具发布 眼健康是国民健康的重要组成部分，是涉及民生的重大公共卫生问题和社会问题。我国流行病学研究显示，干眼发病率达21%～30%，干眼症已成为影响国民健康和生活质量的常见眼表疾病。 当天，由华厦眼科医院集团及厦门大学眼科研究所推出的AI眼科筛查工具——"智眼守护"小程序正式发布。作为国内首个干眼AI自测工具，该程序通过智能分析用户上传的图片、视频及症状评估 国际眼科科学院院士刘祖国教授在《干眼的危害与AI诊疗新技术》主题讲座中指出："随着电子设备的普及，干眼症已成为现代人不得不面对的常见问题。科学用眼、调整生活习惯、定期检查是 校企融合："眼科技术联合转化中心"揭牌 在活动现场，上海大学转化医学研究院、华厦眼科医院集团以及苏州上海大学 ...

Group 1 - The core viewpoint of the article highlights Huaxia Eye Hospital's current stock performance, with a closing price of 19.24 yuan, an increase of 1.21%, and a rolling PE ratio of 38.26 times, with a total market value of 16.162 billion yuan [1] - The average PE ratio for the medical services industry is 41.42 times, with a median of 44.32 times, placing Huaxia Eye Hospital at the 28th position in the industry ranking [1] - As of the first quarter of 2025, 18 institutions hold shares in Huaxia Eye Hospital, including 10 funds and 8 other entities, with a total holding of 192.8128 million shares valued at 3.843 billion yuan [1] Group 2 - Huaxia Eye Hospital's main business is specialized ophthalmic medical services, with key products including cataract projects, posterior segment projects, refractive projects, and comprehensive optometry projects [1] - The latest performance report for the first quarter of 2025 shows the company achieved an operating income of 1.093 billion yuan, a year-on-year increase of 11.74%, and a net profit of 150 million yuan, reflecting a year-on-year decrease of 4.00%, with a gross profit margin of 44.97% [1]

证券代码：301267 证券简称：华厦眼科 公告编号：2025-020 华厦眼科医院集团股份有限公司 关于注销部分募集资金专项账户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、募集资金基本情况 经中国证券监督管理委员会《关于同意华厦眼科医院集团股份有限公司首次 公开发行股票注册的批复》（证监许可〔2022〕2085 号）同意，华厦眼科医院 集团股份有限公司（以下简称"公司"）首次公开发行人民币普通股（A 股）股票 6,000.00 万股，每股发行价格为人民币 50.88 元，募集资金总额为人民币 3,052,800,000.00 元，扣除不含税的发行费用人民币 284,307,454.70 元，实际募集 资金净额为人民币 2,768,492,545.30 元。容诚会计师事务所（特殊普通合伙）对 募集资金到位情况进行了审验，并出具了《验资报告》（容诚验字[2022]361Z0068 号）。 | | 门厦禾支行 | | | | --- | --- | --- | --- | | 6 | 兴业银行股份有限公司厦门分 | 1296801001012086 ...

证券代码：301267 证券简称：华厦眼科 公告编号：2025-019 华厦眼科医院集团股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会不存在否决议案的情形。 2、本次股东大会不涉及变更前次股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、股东大会届次：2024 年年度股东大会。 2、会议召开时间 （1）现场会议时间：2025 年 5 月 20 日下午 15:00； （2）网络投票时间：2025 年 5 月 20 日； 通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 5 月 20 日 9:15-9:25、9:30-11:30 和 13:00-15:00； 通过深圳证券交易所互联网投票系统投票的具体时间为：2025 年 5 月 20 日 9:15-15:00。 3、会议地点：厦门市湖里区五通西路 999 号 17 楼大会议室。 4、会议召开方式：本次股东大会采用现场投票与网络投票相结合的方式召 开。 （二）会议出席情况 1、通过现场和网络投票的股东 ...

上海市锦天城律师事务所 关于华厦眼科医院集团股份有限公司 2024 年年度股东大会的 法律意见书 致：华厦眼科医院集团股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受华厦眼科医院集团股份有 限公司（以下简称"公司"）委托，就公司召开 2024 年年度股东大会（以下简 称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称 "《公司法》"）《上市公司股东会规则》等法律、法规、规章和其他规范性文件 以及《华厦眼科医院集团股份有限公司章程》（以下简称"《公司章程》"）的 有关规定，出具本法律意见书。 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于华厦眼科医院集团股份有限公司 2024 年年度股东大会的 法律意见书 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会所涉及的 ...

Group 1 - The core viewpoint of the articles highlights the performance and market position of Huaxia Eye Hospital Group, noting its stock price increase and market capitalization [1] - As of May 20, the closing price of Huaxia Eye Hospital was 19.21 yuan, with a PE ratio of 38.20 times and a total market value of 16.136 billion yuan [1] - The average PE ratio for the medical services industry is 38.49 times, with a median of 39.26 times, placing Huaxia Eye Hospital at the 28th position in the industry ranking [1][2] Group 2 - As of the first quarter of 2025, 18 institutions held shares in Huaxia Eye Hospital, including 10 funds, with a total holding of 192.8128 million shares valued at 3.843 billion yuan [1] - The main business of Huaxia Eye Hospital includes specialized ophthalmic medical services, focusing on cataract projects, posterior segment projects, refractive projects, and comprehensive optometry projects [1] - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 1.093 billion yuan, a year-on-year increase of 11.74%, and a net profit of 150 million yuan, reflecting a year-on-year decrease of 4.00%, with a gross profit margin of 44.97% [1]